Chloroquine Has Only Limited Effect on HIV-Induced Immune Activation

A new study designed to assess the ability of chloroquine, a Toll-like receptor inhibitor, to reduce immune system activation and inflammation caused by chronic HIV infection showed chloroquine to be only somewhat effective. The modest reduction in immune activation seen in HIV-infected patients on antiretroviral therapy (ART) would be unlikely to produce substantial clinical benefit, conclude the researchers in an article in AIDS Research and Human Retroviruses, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers ( The article is available free on the AIDS Research and Human Retroviruses ( website until September 4, 2016.

Jeffrey Jacobson and a team of coauthors representing the AIDS Clinical Trial Group A5258 Protocol Team describe the study design and interpret the results in the article entitled "The Effect of Chloroquine on Immune Activation and Interferon Signatures Associated with HIV-1 (" The researchers treated two groups of HIV-infected patients-those on or off ART-with either 250 mg oral chloroquine or placebo for 12 weeks in a crossover study design.

"In order to develop effective treatments for HIV, it is just as important to determine what does not work," says Thomas Hope, PhD, Editor-in-Chief of AIDS Research and Human Retroviruses and Professor of Cell and Molecular Biology at Northwestern University, Feinberg School of Medicine (Chicago, IL). "These negative results redirect research efforts to develop alternative approaches that could be effective for controlling the immune activation associated with HIV-induced disease."

Research reported in this publication was supported by the National Institute of Allergy and Infectious Diseases under Award Numbers UM1 AI068634, AI068636, AI76174, AI36219, and UM1 AI106701, and National Institutes of Health AIDS Clinical Trial Group Site Grants. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Full bibliographic information

The Effect of Chloroquine on Immune Activation and Interferon Signatures Associated with HIV-1
Jacobson Jeffrey M., Bosinger Steven E., Kang Minhee, Belaunzaran-Zamudio Pablo, Matining Roy M., Wilson Cara C., Flexner Charles, Clagett Brian, Plants Jill, Read Sarah, Purdue Lynette, Myers Laurie, Boone Linda, Tebas Pablo, Kumar Princy, Clifford David, Douek Daniel, Silvestri Guido, Landay Alan L., Lederman Michael M., and for the AIDS Clinical Trial Group A5258 Protocol Team. AIDS Research and Human Retroviruses. June 2016, 32(7): 636-647. doi:10.1089/aid.2015.0336.
Published in Volume: 32 Issue 7: June 27, 2016
Online Ahead of Print: April 19, 2016
Online Ahead of Editing: March 2, 2016
Attached files
  • AIDS Research and Human Retroviruses

Other content in...